Cel-Sci
CVM
#10616
Rank
A$28.85 M
Marketcap
A$1.65
Share price
-4.92%
Change (1 day)
-88.68%
Change (1 year)

Cel-Sci (CVM) - Net assets

Net assets on the balance sheet as of March 2026 : A$9.78 Million

According to Cel-Sci 's latest financial reports the company has A$9.78 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cel-Sci - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$A$24.13 M29.74%
2024-09-30$A$18.6 M-9.5%
2023-09-30$A$20.55 M-58.89%
2022-09-30$A$50 M-36.04%
2021-09-30$A$78.18 M184.02%
2020-09-30$A$27.52 M262.09%
2019-09-30$A$7.6 M599417.08%
2018-09-30$A$0 M-100.03%
2017-09-30$-A$4.26 Million378.3%
2016-09-30$-A$0.89 Million-86.91%
2015-09-30$-A$6.8 Million-156.84%
2014-09-30$A$11.95 M66.27%
2013-09-30$A$7.18 M5.93%
2012-09-30$A$6.78 M-27.18%
2011-09-30$A$9.31 M-67.73%
2010-09-30$A$28.88 M183.72%
2009-09-30$A$10.18 M-25.58%
2008-09-30$A$13.67 M-16.61%
2007-09-30$A$16.4 M-1414.89%
2006-09-30$-A$1.25 Million-145.01%
2005-09-30$A$2.77 M-51.8%
2004-09-30$A$5.75 M218.53%
2003-09-30$A$1.8 M-7.6%
2002-09-30$A$1.95 M-75.98%
2001-09-30$A$8.13 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$115.56 B 1,180,843.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.08 B 133,579.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.73 B 7,400.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$18.08 M 84.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$11.71 B 119,643.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-A$0.79 Billion-8,156.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.74 B 7,509.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$9.76 M-0.23%๐Ÿ‡บ๐Ÿ‡ธ USA